These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males. da Rocha AB, Schneider RF, de Freitas GR, André C, Grivicich I, Zanoni C, Fossá A, Gehrke JT, Pereira Jotz G, Kaufmann M, Simon D, Regner A. Clin Chem Lab Med; 2006; 44(10):1234-42. PubMed ID: 17032136 [Abstract] [Full Text] [Related]
10. Reliability of calcium-binding protein S100B measurement toward optimization of hyperosmolal therapy in traumatic brain injury. Hendoui N, Beigmohammadi MT, Mahmoodpoor A, Ahmadi A, Abdollahi M, Hasanpour M, Hadi F, Khazaeipour Z, Mousavi S, Mojtahedzadeh M. Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):477-85. PubMed ID: 23467946 [Abstract] [Full Text] [Related]
11. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. Pelinka LE, Kroepfl A, Leixnering M, Buchinger W, Raabe A, Redl H. J Neurotrauma; 2004 Nov; 21(11):1553-61. PubMed ID: 15684648 [Abstract] [Full Text] [Related]
18. Serum S100B concentrations are increased after closed head injury in children: a preliminary study. Berger RP, Pierce MC, Wisniewski SR, Adelson PD, Kochanek PM. J Neurotrauma; 2002 Nov; 19(11):1405-9. PubMed ID: 12490005 [Abstract] [Full Text] [Related]
19. Predictive value of neuromarkers supported by a set of clinical criteria in patients with mild traumatic brain injury: S100B protein and neuron-specific enolase on trial: clinical article. Wolf H, Frantal S, Pajenda GS, Salameh O, Widhalm H, Hajdu S, Sarahrudi K. J Neurosurg; 2013 Jun; 118(6):1298-303. PubMed ID: 23451906 [Abstract] [Full Text] [Related]